Page 1 | Search Results | Blood Neoplasia | American Society of Hematology

1-20 of 92

Sort by

Sort Order Select

Journal Articles

A feedforward loop between ACLY and MYC supports T-ALL progression in vivo

Victoria da Silva-Diz, Amartya Singh, Maya Aleksandrova, Oekyung Kim, Christopher Thai, Olga Lancho, Patricia Renck Nunes, Hayley Affronti, Alexia Martínez de Paz, Steven Z. Josefowicz, Xiaoyang Su, Kathryn E. Wellen, Daniel Herranz

Blood Neoplasia (2025) 2 (2): 100069.

https://doi.org/10.1016/j.bneo.2025.100069

Published: 2025

Includes: Supplemental data

Journal Articles

Prognostic impact of RDI of vincristine in patients with DLBCL receiving R-CHOP: a supplementary analysis of JCOG0601

Takahiro Nakashima, Tomotaka Suzuki, Ryunosuke Machida, Kazuyuki Shimada, Tsutomu Kobayashi, Dai Maruyama, Wataru Munakata, Shinsuke Iida, Ken Ohmachi, Tomohiro Kinoshita, Kiyoshi Ando, Hirokazu Nagai

Blood Neoplasia (2025) 2 (2): 100077.

https://doi.org/10.1016/j.bneo.2025.100077

Published: 2025

Includes: Supplemental data

Journal Articles

A novel 3-way translocation involving ETV6 :: IL3 drives AML with eosinophilia

Blood Neoplasia (2025) 2 (2): 100079.

https://doi.org/10.1016/j.bneo.2025.100079

Published: 2025

Includes: Supplemental data

Journal Articles

Single-cell sequencing reveals shared clonal signatures in nonmalignant B and tumor cells in T-prolymphocytic leukemia

Caroline Hesselager, Ingrid Thörn, Millaray Marincevic, Claes Ladenvall, Jonas Almlöf, Sara Löfgren, Simone Weström, Helena Nord, Lesley-Ann Sutton, Lucia Cavelier, Panagiotis Baliakas, Rose-Marie Amini

Blood Neoplasia (2025) 2 (2): 100076.

https://doi.org/10.1016/j.bneo.2025.100076

Published: 2025

Includes: Supplemental data

Journal Articles

Clonal composition of karyotypically normal AML at diagnosis is not affected by the microenvironment

Monika M. Toma, Adam Karami, Margaret Nieborowska-Skorska, Tomasz Skorski

Blood Neoplasia (2025) 2 (2): 100073.

https://doi.org/10.1016/j.bneo.2025.100073

Published: 2025

Journal Articles

New leads to enhance tagraxofusp efficacy in pDC-AML

Morgane Boichut, Margaux Poussard, Xavier Roussel, Imane Belakri, Sabeha Biichlé, Maxime Fredon, Florian Renosi, Romain Boidot, Olivier Adotevi, Christopher Brooks, Francine Garnache-Ottou, Fanny Angelot Delettre

Blood Neoplasia (2025) 2 (2): 100066.

https://doi.org/10.1016/j.bneo.2025.100066

Published: 2025

Includes: Supplemental data

Journal Articles

Targeting transcription-replication conflicts using G-quadruplexes stabilizers in multiple myeloma

Blood Neoplasia (2025) 2 (2): 100072.

https://doi.org/10.1016/j.bneo.2025.100072

Published: 2025

Includes: Supplemental data

Journal Articles

Race and age disparities in randomized trials of acute myeloid leukemia: a systematic review and meta-analysis

Nathalie Loeb, Olivia Katsnelson, Anshika Jain, Parsa Tahvildar, Daniel Teitelbaum, Alejandro Garcia-Horton

Blood Neoplasia (2025) 2 (2): 100070.

https://doi.org/10.1016/j.bneo.2025.100070

Published: 2025

Includes: Supplemental data

Journal Articles

Characterization of fusion transcripts in AML without recurrent genetic abnormalities unravels new putative fusion genes

Blood Neoplasia (2025) 2 (2): 100068.

https://doi.org/10.1016/j.bneo.2025.100068

Published: 2025

Includes: Supplemental data

Journal Articles

Driver mutations in myeloid and lymphoid cells point to multipotent progenitor origin of diverse histiocytic neoplasms

Astrid G. S. van Halteren, Paul G. Kemps, Jelske Forma-Borst, Yanling Xiao, Maud A. J. I. van den Oetelaar, Nina U. Gelineau, Robert M. Verdijk, Lydia E. Vos, Koen D. Quint, Cor van den Bos, Eli L. Diamond, Jan A. M. van Laar

Blood Neoplasia (2025) 2 (2): 100074.

https://doi.org/10.1016/j.bneo.2025.100074

Published: 2025

Includes: Supplemental data

Journal Articles

Clinical correlation and prognostic impact of cytogenetic clone size for myelodysplastic syndromes/neoplasm

Zhuoer Xie, Najla Al Ali, Ling Zhang, Peter Papenhausen, Virginia Olivia Volpe, Onyee Chan, Andrew Kuykendall, Seongseok Yun, Alison Walker, Kendra Sweet, Jeffrey E. Lancet, Eric Padron, David A. Sallman, Rami S. Komrokji

Blood Neoplasia (2025) 2 (2): 100062.

https://doi.org/10.1016/j.bneo.2024.100062

Published: 2025

Includes: Supplemental data

Journal Articles

Tumor-associated myeloid cells support murine T-ALL in the central nervous system via integrin signaling

Ryan S. Humphrey, Seohee Nam, Dennis C. Wylie, Lauren I. R. Ehrlich

Blood Neoplasia 100095.

https://doi.org/10.1016/j.bneo.2025.100095

Published: 2025

Includes: Supplemental data

Journal Articles

Discovery of a novel class NSD2 inhibitor for t(4;14)-positive multiple myeloma

Sae Matsuoka, Naoki Osada, Hirokazu Kubota, Ko Kikuzato, Hiroo Koyama, Takeshi Sonoda, Akiko Idei, Minoru Yoshida, Masaki Kikuchi, Takashi Umehara, Chiduru Watanabe, Teruki Honma, Hiroshi Yasui, Sho Ikeda, Naoto Takahashi, Hideki Nakasone, Jiro Kikuchi, Yusuke Furukawa

Blood Neoplasia 100091.

https://doi.org/10.1016/j.bneo.2025.100091

Published: 2025

Includes: Supplemental data

Journal Articles

Thymic peptides in immune reconstitution and clinical outcome after allogeneic hematopoietic cell transplantation

Hannah Kunstek, Janneke Kieviet, Caroline Lindemans, Coco de Koning, Stefan Nierkens

Blood Neoplasia 100090.

https://doi.org/10.1016/j.bneo.2025.100090

Published: 2025

Journal Articles

Retrospective Evaluation of R-EPOCH in the Frontline Treatment of Adult PTLD Patients Following Solid Organ Transplant

Brian Cuzzo, Maegan Ford, Saagar Jain, Hua-Jay Cherng, Evelyn Orlando, Patrick Gould, Amy Song, Benjamin May, Yuxuan Chen, Govind Bhagat, Andrew H. Lipsky, Barbara Pro, Jennifer E. Amengual

Blood Neoplasia 100094.

https://doi.org/10.1016/j.bneo.2025.100094

Published: 2025

Journal Articles

Improved survival with daratumumab-CyBorD compared to CyBorD as Frontline Therapy In AL Amyloidosis

Blood Neoplasia 100092.

https://doi.org/10.1016/j.bneo.2025.100092

Published: 2025

Includes: Supplemental data

Journal Articles

Genomic Landscape and Clonal Architecture in Pediatric Myeloid Neoplasms with Chromosome 7 Deletions

Tamara Westover, Michael P. Walsh, Sherif Abdelhamed, Emily Xiong, Jing Ma, Guangchun Song, Melvin Thomas, Masayuki Umeda, Jamie L. Maciaszek, Jasmine C. Wong, Astrid Wintering, Lu Wang, Peter D. Emanuel, Mignon L. Loh, Sarah K. Tasian, Elliot Stieglitz, Jason R. Schwartz, Kevin M. Shannon, Jeffery M. Klco

Blood Neoplasia 100093.

https://doi.org/10.1016/j.bneo.2025.100093

Published: 2025

Includes: Supplemental data

Journal Articles

Response and Outcomes of Patients with IDH1/2 Mutated Accelerated/Blast-Phase Myeloproliferative Neoplasms

Blood Neoplasia 100089.

https://doi.org/10.1016/j.bneo.2025.100089

Published: 2025

Includes: Supplemental data

Journal Articles

Multiplex gene editing models of del(7q) reveal combined CUX1 and EZH2 loss drives clonal expansion and drug resistance

Matthew R.M. Jotte, Angela Stoddart, Tanner C. Martinez, Raven Moten, Yuqing Xue, Molly K. Imgruet, Hunter Blaylock, Henna S. Nam, Bonnie Hu, Jermaine Austin, Ningfei An, Saira Khan, Sandeep K. Gurbuxani, Megan E. McNerney

Blood Neoplasia 100083.

https://doi.org/10.1016/j.bneo.2025.100083

Published: 2025

Includes: Supplemental data

Journal Articles

TYK2 is essential for the therapeutic effect of IFN-α in Jak2 V617F-induced murine myeloproliferative neoplasms

Blood Neoplasia 100087.

https://doi.org/10.1016/j.bneo.2025.100087

Published: 2025

Includes: Supplemental data

NARROW

A feedforward loop between ACLY and MYC supports T-ALL progression in vivo

Prognostic impact of RDI of vincristine in patients with DLBCL receiving R-CHOP: a supplementary analysis of JCOG0601

A novel 3-way translocation involving ETV6 :: IL3 drives AML with eosinophilia

Single-cell sequencing reveals shared clonal signatures in nonmalignant B and tumor cells in T-prolymphocytic leukemia

Clonal composition of karyotypically normal AML at diagnosis is not affected by the microenvironment

New leads to enhance tagraxofusp efficacy in pDC-AML

Targeting transcription-replication conflicts using G-quadruplexes stabilizers in multiple myeloma

Race and age disparities in randomized trials of acute myeloid leukemia: a systematic review and meta-analysis

Characterization of fusion transcripts in AML without recurrent genetic abnormalities unravels new putative fusion genes

Driver mutations in myeloid and lymphoid cells point to multipotent progenitor origin of diverse histiocytic neoplasms

Clinical correlation and prognostic impact of cytogenetic clone size for myelodysplastic syndromes/neoplasm

Tumor-associated myeloid cells support murine T-ALL in the central nervous system via integrin signaling

Discovery of a novel class NSD2 inhibitor for t(4;14)-positive multiple myeloma

Thymic peptides in immune reconstitution and clinical outcome after allogeneic hematopoietic cell transplantation

Retrospective Evaluation of R-EPOCH in the Frontline Treatment of Adult PTLD Patients Following Solid Organ Transplant

Improved survival with daratumumab-CyBorD compared to CyBorD as Frontline Therapy In AL Amyloidosis

Genomic Landscape and Clonal Architecture in Pediatric Myeloid Neoplasms with Chromosome 7 Deletions

Response and Outcomes of Patients with IDH1/2 Mutated Accelerated/Blast-Phase Myeloproliferative Neoplasms

Multiplex gene editing models of del(7q) reveal combined CUX1 and EZH2 loss drives clonal expansion and drug resistance

TYK2 is essential for the therapeutic effect of IFN-α in Jak2 V617F-induced murine myeloproliferative neoplasms

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only